BioCentury
ARTICLE | Company News

ImmunoBiology, China National Pharmaceutical Group deal

November 14, 2011 8:00 AM UTC

ImmunoBiology partnered with Lanzhou Institute of Biological Product (LIBP) to co-develop ImmunoBiology's T-BioVax vaccine to treat tuberculosis (TB) in China. The vaccine is based on ImmunoBiology's ...